Inhibition of TRPV4/calcium/NF-κB signaling pathway attenuates hepatic oxidative stress and inflammatory injury.The combination of TM and HAL has great potential for the treatment of hepatocellular carcinoma by reducing tumour hypoxia and angiogenesis. This evidence concerns the gene NFKB1 and neoplasm.